← Leaderboards
Maribel Almonte
International Agency For Res On Cancer
$2,831,005
Attributed
$2,831,005
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$2,831,005 · 1
By mechanism
UH3$2,831,005 · 1
Top collaborators
No co-investigators on record.
Most similar at International Agency For Res On Cancer
Same institution · by research overlap
- Partha Basu$5,397,794
- Sean Vahram Tavtigian$12,922,427
- Paul Joseph Brennan$16,689,806
- Tarik Gheit$288,712
- Shama Virani$541,269
Others in their field
Other Emerging Leaders on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- Lynn Briscoe · Leidos Biomedical Research, Inc.$100,239,656
- Leonard Freedmand · Leidos Biomedical Research, Inc.$63,918,621
- Mark Marino · Venturewell$61,502,138
- Scott Topper · Broad Institute, Inc.$51,811,587
Research focus
DiagnosticAcronymsBaseDiagnosisBiopsyBurden Of IllnessCancer DetectionCancer EtiologyBiologyDeveloping CountriesCervicalCervical Cancer ScreeningCharacteristicsClinicClinical AssessmentsColombiaColposcopyCountryCytologyCancer Research NetworkCarcinogenicityArgentinaDeveloped CountriesDiagnostic Procedure
Grant awards (4)
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries$756,503
UH3 · FY2021 · CA · contact PI
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries$350,000
UH3 · FY2021 · CA · contact PI
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries$850,346
UH3 · FY2020 · CA · contact PI
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries$874,156
UH3 · FY2019 · CA · contact PI